Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
The British Journal of Dermatology
|
October 13, 2020
Aetiology and pathogenesis of hidradenitis suppurativa
K Wolk, O Join-Lambert, R Sabat
Antimicrobial Agents and Chemotherapy
|
February 27, 2008
Comparison of the in vitro efficacies of moxifloxacin and amoxicillin against Listeria monocytogenes
S Grayo, O Join-Lambert, M C Desroches, et al.
Medecine Et Maladies Infectieuses
|
September 13, 2011
[Pneumonia and Rothia dentocariosa]
A Bousquet, C Soler, C Martinaud, et al.
Journal of Clinical Microbiology
|
April 13, 2007
Evaluation of moxalactam with the BD phoenix system for detection of methicillin resistance in coagulase-negative staphylococci
H Pupin, H Renaudin, O Join-Lambert, et al.
Antimicrobial Agents and Chemotherapy
|
April 4, 1998
Critical importance of in vivo amoxicillin and cefotaxime concentrations for synergy in treatment of experimental Enterococcus faecalis endocarditis
O Join-Lambert, J L Mainardi, C Cuvelier, et al.
The British Journal of Dermatology
|
January 21, 2015
First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome
S Duchatelet, S Miskinyte, O Join-Lambert, et al.
The Journal of Hospital Infection
|
July 13, 2013
Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?
T Goulenok, A Ferroni, E Bille, et al.
Infectious Diseases Now
|
November 9, 2020
Rothia spp. infective endocarditis: A systematic literature review
F Franconieri, O Join-Lambert, C Creveuil, et al.
Annales De Medecine Interne
|
January 1, 1996
[Acute blood spoliation: an unrecognized hemolytic factor allowing clinical expression of erythroblastopenia caused by parvoviruses B19 in healthy subjects]
O Join-Lambert, J P de Jaureguiberry, J J de Pina, et al.
Antimicrobial Agents and Chemotherapy
|
April 30, 2014
Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli
H Guet-Revillet, A Emirian, M Groh, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
The British Journal of Dermatology
|
October 13, 2020
Aetiology and pathogenesis of hidradenitis suppurativa
K Wolk, O Join-Lambert, R Sabat
Antimicrobial Agents and Chemotherapy
|
February 27, 2008
Comparison of the in vitro efficacies of moxifloxacin and amoxicillin against Listeria monocytogenes
S Grayo, O Join-Lambert, M C Desroches, et al.
Medecine Et Maladies Infectieuses
|
September 13, 2011
[Pneumonia and Rothia dentocariosa]
A Bousquet, C Soler, C Martinaud, et al.
Journal of Clinical Microbiology
|
April 13, 2007
Evaluation of moxalactam with the BD phoenix system for detection of methicillin resistance in coagulase-negative staphylococci
H Pupin, H Renaudin, O Join-Lambert, et al.
Antimicrobial Agents and Chemotherapy
|
April 4, 1998
Critical importance of in vivo amoxicillin and cefotaxime concentrations for synergy in treatment of experimental Enterococcus faecalis endocarditis
O Join-Lambert, J L Mainardi, C Cuvelier, et al.
The British Journal of Dermatology
|
January 21, 2015
First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome
S Duchatelet, S Miskinyte, O Join-Lambert, et al.
The Journal of Hospital Infection
|
July 13, 2013
Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?
T Goulenok, A Ferroni, E Bille, et al.
Infectious Diseases Now
|
November 9, 2020
Rothia spp. infective endocarditis: A systematic literature review
F Franconieri, O Join-Lambert, C Creveuil, et al.
Annales De Medecine Interne
|
January 1, 1996
[Acute blood spoliation: an unrecognized hemolytic factor allowing clinical expression of erythroblastopenia caused by parvoviruses B19 in healthy subjects]
O Join-Lambert, J P de Jaureguiberry, J J de Pina, et al.
Antimicrobial Agents and Chemotherapy
|
April 30, 2014
Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli
H Guet-Revillet, A Emirian, M Groh, et al.
Page
of 2